Amarin Appoints New CMO, Elects Directors
Ticker: AMRN · Form: 8-K · Filed: Oct 7, 2024 · CIK: 897448
| Field | Detail |
|---|---|
| Company | Amarin Corp PLC\UK (AMRN) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-appointments, personnel
Related Tickers: AMRN
TL;DR
Amarin shakes up leadership with a new CMO and two board members.
AI Summary
Amarin Corporation plc announced on October 1, 2024, the appointment of Dr. Karim Mikhail as Chief Medical Officer and the election of Ms. Sarah B. Greenberg and Mr. David M. Stack to its Board of Directors. The company also disclosed compensatory arrangements for certain officers.
Why It Matters
These executive and board changes could signal a shift in the company's strategic direction or leadership focus, potentially impacting its future operations and market performance.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Amarin Corporation plc (company) — Registrant
- Dr. Karim Mikhail (person) — Appointed Chief Medical Officer
- Ms. Sarah B. Greenberg (person) — Elected to Board of Directors
- Mr. David M. Stack (person) — Elected to Board of Directors
- October 1, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Karim Mikhail has been appointed as the new Chief Medical Officer.
Who were elected to Amarin's Board of Directors?
Ms. Sarah B. Greenberg and Mr. David M. Stack were elected to Amarin's Board of Directors.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is October 1, 2024.
What other information is disclosed regarding officers?
The filing also discloses compensatory arrangements of certain officers.
What is Amarin Corporation's jurisdiction of incorporation?
Amarin Corporation is incorporated in England and Wales.
Filing Stats: 569 words · 2 min read · ~2 pages · Grade level 13.7 · Accepted 2024-10-07 16:15:07
Filing Documents
- amrn-20241001.htm (8-K) — 45KB
- 0000950170-24-113227.txt ( ) — 170KB
- amrn-20241001.xsd (EX-101.SCH) — 32KB
- amrn-20241001_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 7, 2024 Amarin Corporation plc By: /s/ Aaron Berg Aaron Berg President and Chief Executive Officer ACTIVE/122789132.1